Latest Insider Transactions at Akero Therapeutics, Inc. (AKRO)
This section provides a real-time view of insider transactions for Akero Therapeutics, Inc. (AKRO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Akero Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Akero Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Aug 28
2023
|
Catriona Yale Chief Development Officer |
SELL
Open market or private sale
|
Direct |
5,745
-5.54%
|
$287,250
$50.29 P/Share
|
Aug 28
2023
|
Catriona Yale Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,745
+9.89%
|
$34,470
$6.36 P/Share
|
Aug 08
2023
|
G. Walmsley Graham |
BUY
Open market or private purchase
|
Indirect |
25,000
+4.0%
|
$1,050,000
$42.06 P/Share
|
Aug 01
2023
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-2.68%
|
$1,075,000
$43.18 P/Share
|
Aug 01
2023
|
Andrew Cheng President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+5.02%
|
$150,000
$6.36 P/Share
|
Aug 01
2023
|
G. Walmsley Graham |
BUY
Open market or private purchase
|
Indirect |
25,000
+4.17%
|
$1,075,000
$43.26 P/Share
|
Jul 28
2023
|
G. Walmsley Graham |
BUY
Open market or private purchase
|
Indirect |
30,000
+5.17%
|
$1,260,000
$42.69 P/Share
|
Jul 03
2023
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-1.78%
|
$1,125,000
$45.44 P/Share
|
Jul 03
2023
|
Andrew Cheng President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+5.02%
|
$150,000
$6.36 P/Share
|
Jun 27
2023
|
Andrew Cheng President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+8.2%
|
$0
$0.62 P/Share
|
Jun 23
2023
|
Catriona Yale Chief Development Officer |
SELL
Open market or private sale
|
Direct |
11,000
-9.64%
|
$561,000
$51.07 P/Share
|
Jun 22
2023
|
Catriona Yale Chief Development Officer |
SELL
Open market or private sale
|
Direct |
11,000
-16.03%
|
$572,000
$52.18 P/Share
|
Jun 21
2023
|
Catriona Yale Chief Development Officer |
SELL
Open market or private sale
|
Direct |
11,349
-14.19%
|
$590,148
$52.26 P/Share
|
Jun 20
2023
|
William Richard White Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
20,777
-52.1%
|
$1,142,735
$55.0 P/Share
|
Jun 20
2023
|
William Richard White Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,500
+30.5%
|
$122,500
$7.01 P/Share
|
Jun 16
2023
|
Tomas J. Heyman |
SELL
Open market or private sale
|
Direct |
26,000
-100.0%
|
$1,404,000
$54.67 P/Share
|
Jun 16
2023
|
Tomas J. Heyman |
BUY
Exercise of conversion of derivative security
|
Direct |
26,000
+50.0%
|
$650,000
$25.04 P/Share
|
Jun 16
2023
|
Timothy Rolph Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
78,200
-12.56%
|
$4,301,000
$55.32 P/Share
|
Jun 16
2023
|
Timothy Rolph Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+14.85%
|
$0
$0.61 P/Share
|
Jun 16
2023
|
Jane Henderson |
SELL
Open market or private sale
|
Direct |
40,000
-71.88%
|
$2,160,000
$54.13 P/Share
|
Jun 16
2023
|
Jane Henderson |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+50.0%
|
$280,000
$7.01 P/Share
|
Jun 13
2023
|
William Richard White Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
606
-2.64%
|
$33,330
$55.16 P/Share
|
Jun 13
2023
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
538
-0.29%
|
$29,590
$55.16 P/Share
|
Jun 13
2023
|
Timothy Rolph Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
509
-0.27%
|
$27,995
$55.16 P/Share
|
Jun 13
2023
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
1,613
-0.39%
|
$88,715
$55.16 P/Share
|
Jun 13
2023
|
Catriona Yale Chief Development Officer |
SELL
Open market or private sale
|
Direct |
591
-0.73%
|
$32,505
$55.16 P/Share
|
Jun 01
2023
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-1.94%
|
$1,125,000
$45.11 P/Share
|
Jun 01
2023
|
Andrew Cheng President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+2.78%
|
$75,000
$3.49 P/Share
|
May 19
2023
|
G. Walmsley Graham |
BUY
Open market or private purchase
|
Indirect |
120,000
+18.75%
|
$5,040,000
$42.0 P/Share
|
May 01
2023
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-2.9%
|
$1,125,000
$45.25 P/Share
|
May 01
2023
|
Andrew Cheng President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+5.44%
|
$0
$0.62 P/Share
|
Apr 18
2023
|
Andrew Cheng President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+8.9%
|
$0
$0.62 P/Share
|
Apr 03
2023
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-3.18%
|
$950,000
$38.36 P/Share
|
Apr 03
2023
|
Andrew Cheng President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+5.96%
|
$0
$0.62 P/Share
|
Mar 10
2023
|
William Richard White Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
641
-2.71%
|
$27,563
$43.47 P/Share
|
Mar 10
2023
|
Jonathan Young Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
634
-0.34%
|
$27,262
$43.47 P/Share
|
Mar 10
2023
|
Catriona Yale Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
701
-0.86%
|
$30,143
$43.46 P/Share
|
Mar 10
2023
|
Andrew Cheng President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,706
-0.46%
|
$73,358
$43.47 P/Share
|
Mar 10
2023
|
Timothy Rolph Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
603
-0.32%
|
$25,929
$43.47 P/Share
|
Mar 01
2023
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-2.14%
|
$1,150,000
$46.44 P/Share
|
Mar 01
2023
|
Andrew Cheng President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+5.94%
|
$0
$0.62 P/Share
|
Feb 01
2023
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-2.14%
|
$1,225,000
$49.46 P/Share
|
Feb 01
2023
|
Andrew Cheng President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+5.94%
|
$0
$0.62 P/Share
|
Jan 13
2023
|
Catriona Yale Chief Development Officer |
SELL
Open market or private sale
|
Direct |
5,000
-1.48%
|
$250,000
$50.55 P/Share
|
Jan 03
2023
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-1.08%
|
$1,300,000
$52.54 P/Share
|
Jan 03
2023
|
Andrew Cheng President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+5.94%
|
$0
$0.62 P/Share
|
Jan 03
2023
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
8,777
-4.53%
|
$473,958
$54.64 P/Share
|
Jan 03
2023
|
Jonathan Young Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,777
+4.34%
|
$0
$0.62 P/Share
|
Dec 29
2022
|
Timothy Rolph Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
20,316
-4.93%
|
$1,015,800
$50.97 P/Share
|
Dec 29
2022
|
Timothy Rolph Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,816
+3.57%
|
$218,848
$28.35 P/Share
|